by Alex Kadhim
In a nationwide, retrospective cohort study, researchers from St. Mary’s Hospital, Kurume, and a nationwide consortium of Japanese transplant centers have shown that mycophenolate mofetil...
by Alex Kadhim
A recent single-center retrospective study, published in Transplantation and Cellular Therapy, investigated post-transplant outcomes in patients with TP53-mutated or 17p-deleted myeloid...
by Alex Kadhim
In a single-center phase 2 study (CAR-PRISM; NCT05767359), researchers from the Dana Farber Cancer Institute have shown that a single infusion of BCMA-directed CAR T cell therapy with...
by Blood Advances
Toxicities related to axicabtagene ciloleucel (axi-cel) can be safely and effectively managed, suggest findings from a single-center study.
by Clinical Cancer Research
While evidence suggests that increasing the share of stem cell-like memory T cells (TSCM) in chimeric antigen receptor (CAR) T-cell products might support immunotherapy for solid tumors, a Phase I...
by Blood Advances
Donor T cells that overexpress the protein BCL2, including those enriched after steroid exposure, protect against graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell...